Search results
Found 6218 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
An unexpected role for the cell’s largest membrane network
7 April 2022
A new Klemm Lab-led paper has uncovered a new mechanism involving the endoplasmic reticulum that is critical to the organisation and position of the microtubule (MT) cytoskeleton, which ultimately dictates the shape and function of our body’s cells.
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
6 April 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
Research staff representatives connect to shape research culture
6 April 2022
Representatives from across Medical Sciences Division departments came together in a workshop to strengthen the research staff community and discuss organisational cultures.
First-ever Evidence-Based Health Care Summer School to take place this summer
5 April 2022
Led by the Centre for Evidence-Based Medicine, and jointly run by the Department for Continuing Education, this summer school invites EBHC students, supervisors, consumers, and leading evidence-based experts into the surroundings of Kellogg College, University of Oxford. 4-20 July. Spanning three weeks this unique experience offers: EBHC modules; non-accredited short courses; a selection of workshops and EBMLive 2022.
Oxford University retains top spot for spinout generation in the UK
4 April 2022
Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.
Charity Commission notice about the Nuffield Dominions Trust
4 April 2022
This a formal notice about a proposed Charity Commission Scheme to extend the geographical scope of the Nuffield Dominions Trust.
New research suggests targeting blood vessels could be key to controlling fibrotic disease
1 April 2022
By studying blood vessels at single cell resolution, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
The glass half full man: Professor Chas Bountra and Oxford's innovative future
1 April 2022
Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.
AI helps to detect bone fractures to 92% accuracy
31 March 2022
Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial Intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.
Defining the role of resident memory B cells in the fight against influenza
31 March 2022
Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
No increased risk of brain tumours for mobile phone users, new study finds
30 March 2022
Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.
Little understood brain region linked to how we perceive pain
29 March 2022
A new review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
New insights into little understood regulator of blood sugar levels
28 March 2022
A new study has uncovered the role of ACC1 enzyme in the regulation of glucagon secretion for the first time. This raises the prospect of a potential new therapeutic target in the context of type 2 diabetes and metabolic disorders characterised by hyperglycaemia.
The RECOVERY Trial - two years on
23 March 2022
One trial. Over 47,000 participants. Nearly 200 hospital sites, across six countries. Ten results. Four effective COVID-19 treatments. And behind them all, an army of countless researchers, doctors, nurses, statisticians and supporting staff.
Athena Swan Silver Award renewal for Nuffield Department of Surgical Sciences
23 March 2022
Nuffield Department of Surgical Sciences have been successful in the renewal of their Athena Swan Silver Award, recognising their work in advancing gender equality.
Oxford launches new Bennett Institute for Applied Data Science and Ben Goldacre announced as the first Bennett Professor of Evidence-Based Medicine
23 March 2022
The use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine
Largest genetic study of pleural infection reveals complex nature of common disease
21 March 2022
A new genetic study of the bacteria that cause pleurisy has shown most cases involve more than one type of bacterium, and revealed which bacterial combinations cause the most serious infections.
No link found between COVID-19 vaccines and neurological events
16 March 2022
Researchers from Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) found no evidence that COVID-19 vaccines cause neurological disorders. But they did find an increased risk for unvaccinated people infected with SARS-CoV-2.
Oxford researchers awarded funding to study the immune response to malaria
15 March 2022
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”
Oxford leads global cross-collaboration Covid research
14 March 2022
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.